Resveratrol Attenuates Non-alcoholic Fatty Liver Disease in Obese Mice Modulating MAF1
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2022/09/21
-
Indian UGC (journal)
-
Refrences50
-
Citations3
-
Karinne Aparecida Souza Silva ORCID (unauthenticated)
-
Daniela Fernanda Freitas ORCID (unauthenticated)
-
Luciana Mendes Araújo Borém ORCID (unauthenticated)
-
Luís Paulo Oliveira ORCID (unauthenticated)
-
Janaína Ribeiro Oliveira ORCID (unauthenticated)
-
Alanna Fernandes Paraíso ORCID (unauthenticated)
-
André Luiz Sena Guimarães ORCID (unauthenticated)
-
Alfredo Maurício Batista de Paula ORCID (unauthenticated)
-
Carlos Eduardo Mendes D’Angelis ORCID (unauthenticated)
-
Sergio Henrique Sousa Santos ORCID (unauthenticated)
Cite
Silva, Karinne Aparecida Souza, et al. “Resveratrol Attenuates Non-Alcoholic Fatty Liver Disease in Obese Mice Modulating MAF1”. Revista Brasileira De Farmacognosia, vol. 32, no. 5, 2022, pp. 786-95, https://doi.org/10.1007/s43450-022-00309-y.
Silva, K. A. S., Freitas, D. F., Borém, L. M. A., Oliveira, L. P., Oliveira, J. R., Paraíso, A. F., Guimarães, A. L. S., de Paula, A. M. B., D’Angelis, C. E. M., & Santos, S. H. S. (2022). Resveratrol Attenuates Non-alcoholic Fatty Liver Disease in Obese Mice Modulating MAF1. Revista Brasileira De Farmacognosia, 32(5), 786-795. https://doi.org/10.1007/s43450-022-00309-y
Silva KAS, Freitas DF, Borém LMA, Oliveira LP, Oliveira JR, Paraíso AF, et al. Resveratrol Attenuates Non-alcoholic Fatty Liver Disease in Obese Mice Modulating MAF1. Revista Brasileira de Farmacognosia. 2022;32(5):786-95.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Insulin resistance and insulin sensitizing agents | Metabolism |
| 85 | 2021 |
It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them? | International Journal of Molecular Sciences |
| 65 | 2021 |
| Effect of resveratrol on expression of genes involved thermogenesis in mice and humans | Biomedicine & Pharmacotherapy |
| 41 | 2019 |
Rodent Models of Nonalcoholic Fatty Liver Disease | Digestion |
| 65 | 2019 |
| 10.1042/BCJ20180008 | 2018 |
Refrences Analysis
The category
Science: Biology (General) 11
is the most frequently represented among the references in this article. It primarily includes studies from European Journal of Nutrition and Journal of Medicinal Chemistry. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? | International Journal of Molecular Sciences |
| 2024 | |
Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease/nonalcoholic steatohepatitis | Phytotherapy Research |
| 5 | 2023 |
Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review | Scientia Pharmaceutica |
| 1 | 2023 |
Citations Analysis
The category
Medicine: Therapeutics. Pharmacology 2
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review and was published in 2023. The most recent citation comes from a 2024 study titled Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?. This article reached its peak citation in 2023, with 2 citations. It has been cited in 3 different journals, 33% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.